首页> 外国专利> DERIVATIVES OF ANTHRANILIC ACID, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF

DERIVATIVES OF ANTHRANILIC ACID, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF

机译:邻氨基苯甲酸的衍生物,其合成方法和基于其的药物成分

摘要

FIELD: organic chemistry, biochemistry, pharmacy. SUBSTANCE: invention relates to novel derivatives of anthranilic acid of the formula (I) where R1, R2 mean H, alkyl, OH, alkoxy-group, halogen atom, nitro-group, N(R10R11); R3 means H, alkyl; R4 means alkyl or R4 means -CH2- or -CH2CH2- that is bound either at position 2 of cycle b completing saturated 5- or 6-membered nitrogen-containing cycle or at position 2 of cycle a with which X is bound by a single bond completing saturated 5- or 6-membered nitrogen-containing cycle; R5 means H, OH, alkyl; X means a single bond, O, S, -O--(CH2)p- where p is a number from 1 to 6; R6 means H, alkyl, alkoxy-group; q is a number from 0 to 1; Ar means phenyl, naphthyl or heterocyclic group containing S or N; each among R7 and R8 means H, alkyl, alkoxy-group, hydroxy-group, phenyl, -NHOH, nitro-group, N(R10R11), SR12; or each among R7 and R8 in common with carbon atoms forms benzene or methylenedioxy- -substitute; R9 means phenyl or heterocyclic group containing 1 or 2 atoms among O, S or N; n = 0 or 1; m = 0-3. Compounds of the formula (I) show activity as inhibitor of P-glycoprotein and can be used in pharmaceutical composition and for enhancement of cytotoxic effect of chemotherapeutic agent. Also, invention relates to methods of synthesis of compounds of the formula (I) and formula (Ia) that involve treatment of compound of the formula (VI) with carboxylic acid, compound of the formula (XII) with compound of the formula (XX) , compound of the formula (VIII') with carboxylic acid, compound of the formula (XII') with compound of the formula (IX') and compound of the formula (XIII') with compound of the formula (IX') . EFFECT: improved methods of synthesis, valuable medicinal properties of compounds. 17 cl, 19 tbl, 7 sch, 23 ex
机译:领域:有机化学,生物化学,药学。物质:本发明涉及式(I)的邻氨基苯甲酸的新型衍生物。<图像文件=“ 00000011.GIF” he =“ 43” id =“ imag00000011” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 108” />其中R 1 ,R 2 表示H,烷基,OH,烷氧基,卤素原子,硝基,N(R 10 R 11 ); R 3 表示H,烷基; R 4 表示烷基或R 4 表示-CH 2 -或-CH 2 CH 2 < / Sub>-结合在循环b的2位完成饱和的5或6元含氮循环或结合在循环a的2位上,其中X被单键键合完成5或6元饱和含氮循环R 5 是指H,OH,烷基; X表示单键,O,S,-O-(CH 2 p -,其中p是1至6的数字; R 6 是指H,烷基,烷氧基; q是从0到1的数字; Ar表示含有S或N的苯基,萘基或杂环基。 R 7 和R 8 分别表示H,烷基,烷氧基,羟基,苯基,-NHOH,硝基,N(R 10 R 11 ),SR 12 ;与碳原子共同的R 7 和R 8 中的每一个形成苯或亚甲基二氧基-取代基; R 9 是指在O,S或N中含有1或2个原子的苯基或杂环基。 n = 0或1; m = 0-3。式(I)的化合物显示出作为P-糖蛋白抑制剂的活性,并且可以用于药物组合物中并用于增强化学治疗剂的细胞毒性作用。而且,本发明涉及式(I)和式(Ia)的化合物的合成方法。<图像文件=“ 00000012.GIF” he =“ 43” id =“ imag00000012” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 104” />,涉及处理式(VI)的化合物与羧酸,式(XII)的化合物与公式的化合物(XX),公式的化合物(VIII')<图像文件=“ 00000016.GIF” he =“ 35” id =“ imag00000016” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 30” />与羧酸,式(XII的化合物')<图像文件=“ 00000017.GIF” he =“ 28” id =“ imag00000017” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 41” />,其中包含公式(IX')的化合物<图像文件=“ 00000018.GIF” h e =“ 28” id =“ imag00000018” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 77” />和公式(XIII')的化合物<图像文件=“ 00000019.GIF” he =“ 24” id =“ imag00000019” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 47” />,其中包含公式(IX')的化合物<图像文件=“ 00000020.GIF” he =“ 28” id =“ imag00000020” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 77” />。效果:改进的合成方法,化合物的重要药用特性。 17 cl,19 tbl,7 sch,23前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号